Gordon Stein, CFO of CleanTech Lithium, explains why CTL acquired the 23 Laguna Verde licenses. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksLloyds Regulatory News (LLOY)

Share Price Information for Lloyds (LLOY)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 51.34
Bid: 51.26
Ask: 51.30
Change: 0.20 (0.39%)
Spread: 0.04 (0.078%)
Open: 51.38
High: 51.62
Low: 50.88
Prev. Close: 51.14
LLOY Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Pricing and final result for non US tender offer

23 Jun 2017 15:24

RNS Number : 0598J
Lloyds Banking Group PLC
23 June 2017
 

NOT FOR DISTRIBUTION IN OR INTO OR TO ANY PERSON LOCATED OR RESIDENT IN THE UNITED STATES OF AMERICA (INCLUDING ITS TERRITORIES AND POSSESSIONS) (THE "UNITED STATES") OR IN ANY OTHER JURISDICTION WHERE IT IS UNLAWFUL TO DISTRIBUTE THIS DOCUMENT.

 

LLOYDS BANK PLC ANNOUNCES PRICING, ACCEPTANCE AND FINAL RESULTS OF ITS TENDER OFFERS IN RELATION TO CERTAIN STERLING AND EURO NOTES

23 June 2017

Further to the indicative results announcement made earlier today, Lloyds Bank plc (the "Offeror") hereby announces the pricing, acceptance and final results of its invitations to all Holders of the Notes set out in the table below to tender their outstanding Notes for purchase by the Offeror for cash up to a maximum aggregate nominal amount to be determined by the Offeror in its sole and absolute discretion (being the Maximum Acceptance Amount) (each such invitation an "Offer" and, together, the "Offers").

The Offers were announced on 12 June 2017 and were made subject to the offer and distribution restrictions set out in the tender offer memorandum dated 12 June 2017 (the "Tender Offer Memorandum"). Capitalised terms not otherwise defined in this announcement have the same meaning as assigned to them in the Tender Offer Memorandum.

 

PRICING, ACCEPTANCE AND FINAL RESULTS

 

The Offeror hereby announces that (i) the Maximum Acceptance Amount is equal to £950,273,348 and (ii) it accepts valid tenders of each Series of Notes pursuant to the Offers in an aggregate nominal amount equal to the relevant Series Acceptance Amount as set out in the table below.

 

As stated in the indicative results announcement, the pricing took place at around 2.00 p.m. London time today in the manner described in the Tender Offer Memorandum. The final pricing details are set out below:

Title of Security

ISIN Number

Nominal Amount Validly Tendered

Pro-ration Factor

Series Acceptance Amount

Series Acceptance Amount (Sterling equivalent converted at the Euro FX Rate)

Reference Yield

Repurchase Yield*

Purchase Price

Sterling Notes

£250,000,000 2.500 per cent. Notes due June 2022

XS1239389684

£80,855,000

1

£80,855,000

n.a.

0.376%

1.079%

106.784%

Euro Notes

€1,350,000,000 Floating Rate Notes due September 2019

XS1109333986

€324,329,000

1

€324,329,000

£285,827,972

n.a.

n.a.

Fixed Purchase Price of €1008.50 per €1,000 in aggregate nominal amount

€1,000,000,000 0.625 per cent. Notes due April 2020

XS1219428957

€196,225,000

1

€196,225,000

£172,931,171

-0.108%

-0.108%

102.067%

€1,500,000,000 1.000 per cent. Notes due November 2021

XS1139091372

€434,789,000

0

€0

£0

0.066%

0.116%

103.875%

€1,250,000,000 1.375 per cent. Notes due September 2022

XS1280783983

€298,364,000

1

€298,364,000

£262,945,272

0.162%

0.262%

105.741%

€1,250,000,000 1.250 per cent. Notes due January 2025

XS1167204699

€167,611,000

1

€167,611,000

£147,713,933

0.444%

0.569%

105.016%

______________* On an annualised basis.

 

TOTAL CONSIDERATION

The total amount that will be paid to each Holder on the Settlement Date for the Notes validly submitted for tender and accepted for purchase by the Offeror will be an amount in cash equal to:

(i) the relevant Purchase Price for the Notes, multiplied by each Authorised Denomination in aggregate nominal amount of such Notes (rounded to the nearest €0.01 or £0.01, as applicable, with €0.005 or £0.005 being rounded upwards); plus

(ii) any Accrued Interest Payment payable in respect of the relevant Notes.

 

SETTLEMENT DATE

The Settlement Date is expected to be 27 June 2017.

 

FURTHER INFORMATION

For further information please contact:

 

Investor Relations:

Douglas Radcliffe

Group Investor Relations Director

Telephone: +44 (0)20 7356 1571

Email: douglas.radcliffe@finance.lloydsbanking.com

 

 

Requests for information in relation to the Offers should be directed to:

DEALER MANAGER

Lloyds Bank plc10 Gresham StreetLondon EC2V 7AEUnited KingdomTel: +44 20 7158 2720Attention: Liability Management Groupemail: liability.management@lloydsbanking.com

Requests for information in relation to, and for any documents or materials relating to, the Offers should be directed to:

TENDER AGENT

Lucid Issuer Services LimitedTankerton Works12 Argyle WalkLondon WC1H 8HAUnited KingdomTel: +44 20 7704 0880Attention: Paul Kamminga/Arlind Bytyqiemail: lloydsbank@lucid-is.com

 

 

The Offeror launched, contemporaneously with the launch of the Offers, offers to holders of three series of U.S. dollar denominated notes issued by the Offeror. This announcement does not relate to the U.S. Offer.

 

DISCLAIMER

This announcement must be read in conjunction with the announcements relating to the Offers published via RNS on 12 June 2017 and 23 June 2017 and the Tender Offer Memorandum. This announcement does not constitute an offer or an invitation to participate in the Offers in the United States or in any other jurisdiction in which, or to any person to or from whom, it is unlawful to make such offer or invitation or for there to be such participation under applicable laws.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCPGUGPQUPMGCW
Date   Source Headline
23rd Apr 20246:05 pmRNSTransaction in Own Shares
22nd Apr 20245:55 pmRNSTransaction in Own Shares
19th Apr 20245:41 pmRNSTransaction in Own Shares
18th Apr 20246:01 pmRNSTransaction in Own Shares
17th Apr 20246:10 pmRNSTransaction in Own Shares
16th Apr 20246:11 pmRNSTransaction in Own Shares
15th Apr 20245:59 pmRNSTransaction in Own Shares
12th Apr 20245:57 pmRNSTransaction in Own Shares
11th Apr 20245:37 pmRNSTransaction in Own Shares
11th Apr 20242:00 pmRNSDirector/PDMR Shareholding
10th Apr 20246:02 pmRNSTransaction in Own Shares
9th Apr 20246:07 pmRNSTransaction in Own Shares
8th Apr 20246:02 pmRNSTransaction in Own Shares
4th Apr 20246:05 pmRNSTransaction in Own Shares
4th Apr 202410:10 amRNSPublication of Final Terms
3rd Apr 20246:01 pmRNSTransaction in Own Shares
2nd Apr 20245:56 pmRNSTransaction in Own Shares
28th Mar 20245:46 pmRNSTransaction in Own Shares
28th Mar 20245:39 pmRNSTotal Voting Rights
28th Mar 20245:24 pmRNSPublication of a Prospectus
28th Mar 20249:30 amRNSBlock Listing of Shares
27th Mar 20246:10 pmRNSTransaction in Own Shares
26th Mar 20245:53 pmRNSTransaction in Own Shares
26th Mar 20242:00 pmRNSDirector/PDMR Shareholding
25th Mar 20245:34 pmRNSTransaction in Own Shares
22nd Mar 20246:14 pmRNSPublication of a Prospectus
21st Mar 20246:13 pmRNSTransaction in Own Shares
21st Mar 20244:28 pmRNSNotice of AGM
20th Mar 20246:16 pmRNSTransaction in Own Shares
19th Mar 20246:18 pmRNSTransaction in Own Shares
18th Mar 20246:19 pmRNSTransaction in Own Shares
15th Mar 20246:05 pmRNSTransaction in Own Shares
15th Mar 20242:00 pmRNSDirector/PDMR Shareholding
14th Mar 20245:58 pmRNSTransaction in Own Shares
13th Mar 20246:23 pmRNSTransaction in Own Shares
13th Mar 20243:00 pmRNSDirector/PDMR Shareholding
12th Mar 20246:16 pmRNSTransaction in Own Shares
11th Mar 20246:16 pmRNSTransaction in Own Shares
8th Mar 20245:33 pmRNSTransaction in Own Shares
8th Mar 20241:30 pmRNSDirector/PDMR Shareholding
7th Mar 20246:06 pmRNSTransaction in Own Shares
7th Mar 20242:29 pmRNSDirector/PDMR Shareholding
6th Mar 20246:08 pmRNSTransaction in Own Shares
6th Mar 20245:55 pmRNSHolding(s) in Company
6th Mar 20245:47 pmRNSHolding(s) in Company
5th Mar 20245:25 pmRNSTransaction in Own Shares
5th Mar 202412:21 pmRNSPublication of Final Terms
4th Mar 20246:03 pmRNSTransaction in Own Shares
1st Mar 20245:45 pmRNSTransaction in Own Shares
1st Mar 20243:00 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.